Autologous stem cell therapy with surgical myocardial revascularization - The Rostock University experience;Otolog kök hücre tedavisi ve cerrahi miyokardiyal revaskülarizasyon - Rostock Üniversitesi tecrübesi

Anadolu Kardiyoloji Dergisi

Volumn 9, Issue 6, 2009, Pages 457-464

  Yerebakan, Can ^a   Uǧurlucan, Murat ^a   Kaminski, Alexander ^a   Westphal, Bernd ^a   Liebold, Andreas ^a   Steinhoff, Gustav ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Cardiac surgery; Heart failure; Myocardial ischemia; Stem cell

Indexed keywords

CD133 ANTIGEN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARCINOGENESIS; CHI SQUARE TEST; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; ECHOCARDIOGRAPHY; EVALUATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITORING; HUMAN; MALE; MORTALITY; MYOCARDIAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; RANK SUM TEST; SAFETY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANTIGENS, CD; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CORONARY ARTERY BYPASS; GLYCOPROTEINS; HUMANS; MYOCARDIAL REVASCULARIZATION; PEPTIDES; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS;

EID: 74049162455     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998; 83: 1-14.
2. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763-76.
3. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001; 98: 10344-9.
4. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003; 107: 2294-302.
5. Wollert KC, Drexler H. Mesenchymal stem cells for myocardial infarction: promises and pitfalls. Circulation 2005; 112: 151-3.
6. Ince H, Petzsch M, Kleine HD, Eckard H, Rehders T, Burska D, et al. Prevention of left ventricular remodelling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularisation and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granylocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Circulation 2005; 112: I73-80.
7. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Schümichen C, et al. Autologous bone marrow stem cell transplantation for myocardial regeneration after myocardial infarction. Lancet 2003; 361: 45-6.
8. + bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007; 133: 717-25.
9. Tse HF, Thambar S, Kwong YL, Rowlings P, Bellamy G, McCrohon J, et al. Safety of catheter-based intramyocardial autologous bone marrow cells implantation for therapeutic angiogenesis. Am J Cardiol 2006; 98: 60-2.
10. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41: 1078-83.
11. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000; 102: 898-901.
12. Yoon YS, Park JS, Tkebuchava T, Luedeman C, Losordo DW. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 2004; 109: 3154-7.
13. Uǧurlucan M, Yerebakan C, Furlani D, Ma N, Steinhoff G. Cell sources for cardiovascular tissue regeneration and engineering. Thorac Cardiovasc Surg 2009; 57: 63-73.
14. Akar AR, Durdu S, Çubukçuoǧlu D G, Aslan A, Akçali KC, Ozyurda Ü, et al. Failing heart; remodel, replace or repair? Anadolu Kardiyol Derg 2008; 8 Suppl 2: 148-57.
15. Özbaran M, Omay SB, Nalbantgil S, Kültürsay H, Kumanlioǧlu K, Nart D, et al. Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischemic heart disease. Eur J Cardiothorac Surg 2004; 25: 342-50.
16. Nişanci Y, Tayyareci Y, Sezer M, Umman B. An alternative approach of stem cell delivery to myocardium: combined usage of antegrade coronary arterial infusion and retrograde venous obstruction. Anadolu Kardiyol Derg 2008; 8: 391-2.
17. Garcia L, Baim DS, Post M, Simons M, Laham RJ. Therapeutic angiogenesis using endocardial approach to administration: techniques and results. Curr Interv Cardiol Rep 1999; 1: 222-7.
18. Patel AN, Geffner L, Vina RF, Saslavsky J, Urschel HC, Kormos R, et al. Surgical treatment of congestive heart failure with autologous stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 2005; 130: 1631-8.
19. Fuchs S, Satler LF, Kornowski R, Okubagzi P, Weisz G, Baffour R, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease-A feasibility study. J Am Coll Cardiol 2003; 41: 1721-4.
20. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003; 361: 47-9.
21. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 989-97.